Perfil
Manisha Pai is currently Executive Director-Investor Relations at Vertex Pharmaceuticals, Inc. since 2020.
Former roles include Head-Public Relations at Millennium Pharmaceuticals, Inc. from 2008 to 2013, Head-Public Relations at Pharmacyclics LLC from 2013 to 2014, Head-IR & Corporate Communications at Epizyme, Inc. from 2014 to 2015, Head-IR & Corporate Communications at Genetix Biotherapeutics, Inc. from 2015 to 2017, and Vice President-Investor Relations & Communications at Magenta Therapeutics, Inc. Education includes undergraduate studies at Amherst College.
Cargos activos de Manisha Pai
| Empresas | Cargo | Inicio |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/09/2020 |
Antiguos cargos conocidos de Manisha Pai.
| Empresas | Cargo | Fin |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Contacto de Relaciones con Inversores | 01/10/2017 |
| EPIZYME, INC. | Contacto de Relaciones con Inversores | 01/04/2015 |
| PHARMACYCLICS, INC. | Corporate Officer/Principal | 01/01/2014 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/07/2013 |
| MAGENTA THERAPEUTICS | Contacto de Relaciones con Inversores | - |
Formación de Manisha Pai.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
bluebird bio, Inc.
bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Amherst College
Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Magenta Therapeutics, Inc.
Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
- Bolsa de valores
- Insiders
- Manisha Pai
















